ClinicalTrials.Veeva

Menu

Unilateral Versus Bilateral TLIF for Degenerative Lumbar Spondylolisthesis

K

Kyungpook National University

Status

Unknown

Conditions

Transforaminal Lumbar Interbody Fusion
Degenerative Spondylolisthesis

Treatments

Procedure: Bilateral Transforaminal Interbody fusion
Procedure: Unilateral Transforaminal Interbody fusion

Study type

Interventional

Funder types

Other

Identifiers

NCT03856554
KNUH 2017-04-021-004

Details and patient eligibility

About

A prospective randomized controlled trial for comparison of radiologic outcomes of "single level transforaminal interbody fusion(TLIF) technique via unilateral versus bilateral facetectomy for the treatment of lumbar degenerative spondylolisthesis

Full description

Traditionally many spine surgeons prefer single level TLIF surgery via bilateral facetectomy for increasing union rate. Our hypothesis - "Single level TLIF via unilateral facetectomy is sufficient for achieve successful fusion rate"

Enrollment

52 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • lumbar degenerative spondylolisthesis
  • indicated for surgery

Exclusion criteria

  • not agreed for the study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

52 participants in 1 patient group

Patients indicated for TLIF
Experimental group
Description:
Patients with lumbar degenerative spondylolisthesis, indicated for TLIF surgery
Treatment:
Procedure: Bilateral Transforaminal Interbody fusion
Procedure: Unilateral Transforaminal Interbody fusion

Trial contacts and locations

1

Loading...

Central trial contact

Woo-Kie Min, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems